Full Text
The Full Text of this article is available as a PDF (50.5 KB).
. 2000 Feb;82(4):749–752. doi: 10.1054/bjoc.1999.0991
The promise of anti-angiogenic cancer therapy
M K Oehler
1, R Bicknell
1
M K Oehler
1Molecular Angiogenesis Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK
Find articles by M K Oehler
R Bicknell
1Molecular Angiogenesis Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK
Find articles by R Bicknell
1Molecular Angiogenesis Laboratory, Imperial Cancer Research Fund, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK
Received 1999 Jul 30; Accepted 1999 Sep 10.
Copyright © 2000 Cancer Research Campaign
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
PMCID: PMC2374416 PMID: 10732738